ARTICLE IN PRESS
PCD-443; No. of Pages 7
p r i m a r y c a r e d i a b e t e s x x x ( 2 0 1 5 ) xxx–xxx
Contents lists available at ScienceDirect
Primary Care Diabetes journal homepage: http://www.elsevier.com/locate/pcd
Original research
Glycemic control and use of A1c in primary care patients with type 2 diabetes mellitus Margarita Alonso-Fernández a,b,∗ , José Mancera-Romero c , José Javier Mediavilla-Bravo d , José Manuel Comas-Samper e , Flora López-Simarro f , Ma Paz Pérez-Unanua g , Jesús Iturralde-Iriso h , ˜ on behalf of the Work Group of Diabetes SEMERGEN (Sociedad Espanola 1 de Médicos de Atención Primaria) a
Centro de Salud La Ería, Asturias, Spain Departamento de Medicina Preventiva y Salud Publica, Universidad de Oviedo, Asturias, Spain c Centro de Salud Ciudad Jardín, Málaga, Spain d Centro de Salud Burgos Rural, Burgos, Spain e Centro de Salud La Puebla de Montalban, Toledo, Spain f Área Básica de Salud Martorell, Barcelona, Spain g Centro de Salud Dr. Castroviejo, Madrid, Spain h Centro de Salud Casco Viejo, Álava, Spain b
a r t i c l e
i n f o
a b s t r a c t
Article history:
Aims: To evaluate the degree of glycemic control and its relationship with disease charac-
Received 23 June 2014
teristics and antidiabetic treatment in patients with type 2 diabetes mellitus (DM), as well
Received in revised form
as the frequency of A1c use.
28 December 2014
Methods: For this purpose, an observational, cross-sectorial, and multicenter study was per-
Accepted 22 January 2015
formed. A total of 443 patients were monitored in 17 Spanish primary healthcare centers.
Available online xxx
Demographic and clinical variables were recorded from the clinical history of patients.
Keywords:
A1c was 7.38 ± 1.34% and 45% of patients achieved A1c
PCD-443; No. of Pages 7
p r i m a r y c a r e d i a b e t e s x x x ( 2 0 1 5 ) xxx–xxx
Contents lists available at ScienceDirect
Primary Care Diabetes journal homepage: http://www.elsevier.com/locate/pcd
Original research
Glycemic control and use of A1c in primary care patients with type 2 diabetes mellitus Margarita Alonso-Fernández a,b,∗ , José Mancera-Romero c , José Javier Mediavilla-Bravo d , José Manuel Comas-Samper e , Flora López-Simarro f , Ma Paz Pérez-Unanua g , Jesús Iturralde-Iriso h , ˜ on behalf of the Work Group of Diabetes SEMERGEN (Sociedad Espanola 1 de Médicos de Atención Primaria) a
Centro de Salud La Ería, Asturias, Spain Departamento de Medicina Preventiva y Salud Publica, Universidad de Oviedo, Asturias, Spain c Centro de Salud Ciudad Jardín, Málaga, Spain d Centro de Salud Burgos Rural, Burgos, Spain e Centro de Salud La Puebla de Montalban, Toledo, Spain f Área Básica de Salud Martorell, Barcelona, Spain g Centro de Salud Dr. Castroviejo, Madrid, Spain h Centro de Salud Casco Viejo, Álava, Spain b
a r t i c l e
i n f o
a b s t r a c t
Article history:
Aims: To evaluate the degree of glycemic control and its relationship with disease charac-
Received 23 June 2014
teristics and antidiabetic treatment in patients with type 2 diabetes mellitus (DM), as well
Received in revised form
as the frequency of A1c use.
28 December 2014
Methods: For this purpose, an observational, cross-sectorial, and multicenter study was per-
Accepted 22 January 2015
formed. A total of 443 patients were monitored in 17 Spanish primary healthcare centers.
Available online xxx
Demographic and clinical variables were recorded from the clinical history of patients.
Keywords:
A1c was 7.38 ± 1.34% and 45% of patients achieved A1c
